Skip to content
Screener

Jazz Pharmaceuticals JAZZ Q3 2025 earnings

Reported November 5, 2025 · After market close

Revenue$1.1BBeat by $15.0M
EPS$8.13Beat by $2.18
Revenue estimate$1.1B
EPS estimate$5.95

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$1.2B
EPS estimate$6.47

Financials

Q3 2025

Income statement

See full
Revenue$1.1B+6.7%
Operating income$57.5M-77.9%
Net income$251.4M+16.9%
EPS (diluted)$4.08+19.3%

Balance sheet

See full
Cash & equivalents$1.3B-40.2%
Total debt$5.4B-12.4%
Total equity$4.0B-5.1%
Total assets$11.4B-7.3%

Cash flow

See full
Operating cash flow$474.6M+19.0%
CapEx$15.2M+40.7%
Free cash flow$459.4M+18.4%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$7.99B+14.1%
Enterprise value$12.08B+10.1%
P/S1.9×+0.2×

Profitability

See full
Operating margin-11.9%-28.1pp
Net margin-8.9%-20.5pp
FCF margin32.1%+3.8pp

Returns & leverage

See full
Return on equity-9.1%-21.2pp
Debt / equity1.4×-0.1×
Current ratio1.7×-2.6×

Segments

By product

See full
Xywav$431.4M+11.1%
Epidiolex/Epidyolex$302.6M+20.3%
Rylaze/Enrylaze$99.9M+1.1%
Zepzelca$79.3M-7.6%
High-sodium oxybate AG royalty revenue$52.9M-9.0%

By geography

See full
Europe$86.4M+11.8%
All other$19.2M-19.8%

FAQ

When did Jazz Pharmaceuticals report Q3 2025 earnings?
Jazz Pharmaceuticals (JAZZ) reported Q3 2025 earnings on November 5, 2025 after market close.
What were Jazz Pharmaceuticals's Q3 2025 revenue and EPS?
Jazz Pharmaceuticals reported revenue of $1.1B and eps of $8.13 for Q3 2025.
Did Jazz Pharmaceuticals beat estimates in Q3 2025?
Revenue beat the consensus estimate of $1.1B by $15.0M. EPS beat the consensus estimate of $5.95 by $2.18.
How did Jazz Pharmaceuticals's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 6.7% from $1.1B a year earlier and eps grew 23.0% from $6.61.
Where can I find Jazz Pharmaceuticals's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001232524-25-000073) and the 10-Q periodic report (0001232524-25-000074) directly on SEC EDGAR. The filing index links above go to sec.gov.